# FDA 483 - BioCorRx Inc - August 14, 2020

Source: https://www.globalkeysolutions.net/records/483/biocorrx-inc/58632921-922b-44e0-903b-742a1e37fa24

> FDA 483 for BioCorRx Inc on August 14, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioCorRx Inc
- Inspection Date: 2020-08-14
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: BioCorRx Inc, a sponsor in Anaheim, CA, was inspected by the FDA from July 28 to August 14, 2020. The inspection revealed significant deficiencies in the conduct and monitoring of an investigational drug study. Findings included failures to provide essential study information to investigators, obtain required investigator statements, and maintain adequate records for investigational drug disposition.

## Related Officers

- [Lavender M Huskey](https://www.globalkeysolutions.net/people/lavender-m-huskey/9ad3f3d7-4f25-492a-b10a-ede8289e4797)
- [investigator](https://www.globalkeysolutions.net/people/angela-shepas/743113c1-799b-44e9-9422-8049c476bfd2)

Company: https://www.globalkeysolutions.net/companies/biocorrx-inc/d3c18371-c65c-4202-b000-879f0aaf83d3

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6